Zoetis Community

NYSE:ZTS Community

1 Narratives written by author
0 Comments on narratives written by author
91 Fair Values set on narratives written by author

AN

AnalystConsensusTarget

Consensus Narrative from 16 Analysts

Librela And Solensia Will Improve Pet Pain Management, Driving Future Success

Key Takeaways Zoetis' focus on high-value areas and strategic divestitures enhances operational efficiency, driving revenue and margin expansion. Continued investments in R&D and innovation aim to sustain diversified growth with expectations of annual major approvals and potential blockbusters.

US$198.93

FV

25.3% undervalued

4.46%

Revenue growth p.a.

3

0

53

1 day ago